Growth Metrics

Merck (MRK) Current Deferred Tax Assets (2016 - 2023)

Merck has reported Current Deferred Tax Assets over the past 15 years, most recently at $6.6 billion for Q2 2023.

  • Quarterly Current Deferred Tax Assets fell 2.51% to $6.6 billion in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $6.6 billion through Jun 2023, down 2.51% year-over-year, with the annual reading at $7.2 billion for FY2022, 2.6% up from the prior year.
  • Current Deferred Tax Assets was $6.6 billion for Q2 2023 at Merck, down from $6.7 billion in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $7.2 billion in Q3 2022 and troughed at $3.2 billion in Q1 2019.
  • The 5-year median for Current Deferred Tax Assets is $6.0 billion (2021), against an average of $5.6 billion.
  • Year-over-year, Current Deferred Tax Assets fell 21.38% in 2019 and then soared 49.49% in 2021.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $4.3 billion in 2019, then increased by 9.28% to $4.7 billion in 2020, then soared by 49.49% to $7.0 billion in 2021, then increased by 2.6% to $7.2 billion in 2022, then fell by 7.39% to $6.6 billion in 2023.
  • Per Business Quant, the three most recent readings for MRK's Current Deferred Tax Assets are $6.6 billion (Q2 2023), $6.7 billion (Q1 2023), and $7.2 billion (Q4 2022).